CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

Clinical trial NCT07053462 · RECRUITING

Trial details

NCT number: NCT07053462
Sponsor: AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

End-Stage Renal Disease End Stage Renal Disease on Dialysis End Stage Renal Disease With Renal Transplant Kidney Transplant Rejection Kidney Tumor Kidney Failure Kidney Ischemia

Start date: 2025-06-01
Primary completion: 2027-12-18
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.